Non Alcoholic Fatty Liver Disease
38
1
2
24
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.3%
2 terminated out of 38 trials
92.3%
+5.8% vs benchmark
8%
3 trials in Phase 3/4
25%
6 of 24 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 24 completed trials
Clinical Trials (38)
Characterization of Immune Semaphorin in Non Alcoholic Fatty Liver Disease and NASH
Impact of Artificial Intelligence Algorithm-driven Versus Standard Lifestyle Intervention in Non-Alcoholic Fatty Liver Disease - A Multicenter, Randomized, Open-label, Controlled Trial
Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD
Cardiovascular Risk in Children With Chronic Conditions Study
Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Disease
Relationship Between Eating Patterns, Body Composition and the Detection of Fatty Liver in Children and Adolescents With Trisomy 21: LiverTy Project
The Effect of Exercise Intervention on Insulin Resistance in Non-alcoholic Fatty Liver Disease (NAFLD)
Efficacy and Safety of Pemafibrate for Nonalcoholic Fatty Liver Disease
Amlexanox for Type 2 Diabetes and Obesity
UDFF Performance Evaluation ((Ultrason Derived Fat Fraction)
A Digital Solution for Individuals With Non Alcoholic Fatty Liver Disease
Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD
The Effect of Protein-enriched Diet on Body Composition and Appetite
Mastiha Treatment for Obese With NAFLD Diagnosis
Prevention and Reversion of NAFLD in Obese Patients With Metabolic Syndrome by Mediterranean Diet and Physical Activity
Effect of Dulaglutide on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Nicotinamide in Non-Alcoholic Fatty Liver Disease Patients
Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 Diabetes
Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine
Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease